Predictors of HCV Response to Treatment with Pegylated Interferon and Ribavirin in Sharkia Governorate

Abstract

PEG-INF α2b) were predictors of SVR. Conclusion: Overall SVR among Sharkian patients with CHC, treated with SOC therapy is 50.8%. EVR is the best independent predictor of SVR. The form of PEG-INF may also predict the treatment response. None of the initial pretreatment variables could predict the SVR to treatment with the current SOC for CHC.